Synonym(s)
IFN α-2b; IFN-α-2b; INF alpha-2b; interferon alpha-2b; interferon-alpha-2b; Interferon-α-2b
DefinitionThis section has been translated automatically.
Half-lifeThis section has been translated automatically.
2–3 h
You might also be interested in
IndicationThis section has been translated automatically.
Hair cell leukemia, HIV-associated Kaposi sarcoma, remission maintenance in centroblastic-centrocytic non-Hodgkin lymphomas, melanoma, malignant.
Limited indicationThis section has been translated automatically.
Pregnancy, lactation, psoriasis, COLD, diabetes mellitus tending to ketoacidosis, coagulation disorders, patients < 18 years.
Dosage and method of useThis section has been translated automatically.
2-5 million IU/m2 KO s.c., for Kaposi sarcoma 5 million IU/m2 KO 3 times/week.
Notice! Women of childbearing age should use effective contraception under therapy.
Undesirable effectsThis section has been translated automatically.
S. Interferon alfa-2a.
Notice! In case of hypersensitivity reactions ( urticaria, angioedema, bronchospasm) the drug should be discontinued immediately!
InteractionsThis section has been translated automatically.
Enhanced effect of xanthine derivatives, s.a. Interferon alfa-2a.
ContraindicationThis section has been translated automatically.
Autoimmune diseases, psychiatric history, immunosuppressive treatment.
PreparationsThis section has been translated automatically.
intron A
Prof. Dr. med. Peter Altmeyer